Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
VitalHub Reported Q1 Earnings – Cash Earnings +35%. Revenue $31.9M +47%,...
— Jason & Jesse
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Vitalhub Corp.
VitalHub is our only software investment at the moment.
VitalHub has built a premier healthcare SaaS solution that consistently generates over 20% organic growth. Supported by a...
More institutional theses from DKAM Donville Kent Asset Management
Blue Ant grew revenue 18% per year from 2020 to 2025 with 18% return on capital. The global streaming...
Zedcor raised $30M at $6.00/share in February.
As previously discussed, we sold our Constellation investment in 2025 at $3,250-$3,760/share. We made this...